MedTrace Logo

Prediction and Maintenance of Sinus Rhythm Among Atrial Fibrillation Patients

NCT04313296 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 209

Last updated 2023-08-14

Study results available
· View outcomes & findings →

Summary

Atrial fibrillation (AF) is the most common heart rhythm disorder seen in clinical practice, with an estimated 2.7-6.1 million people in the U.S. affected by the disorder \[1\]. Previous studies have demonstrated that left atrial volume is a predictive measure of incident atrial fibrillation \[2\]. This study aims to add to the literature by investigating predictive measures of left atrial global longitudinal strain (LA GLS) that would be suggestive of maintenance of normal sinus rhythm post cardioversion. If the investigators could gain insight on the connection between LA GLS and cardioversion among patients with atrial fibrillation, the investigators could potentially help the clinical management of patients pre/post cardioversion, and potentially change poor outcomes.

Conditions

Interventions

DEVICE

Unique measurement (AutoSTRAIN) by a commercial software program (TOMTEC-ARENA)

The historic echocardiograms from patients who meet the study inclusion criteria will be uploaded into this software, which was newly acquired by the PBMC Cardiology Department. MaineHealth Information Services are currently working with study staff to assure appropriate security compliance within the network. LA GLS has not been routinely collected previously from echocardiograms performed at PBMC because of a lack of such technology.

Sponsors & Collaborators

  • MaineHealth

    collaborator OTHER

  • Crystal Blake-Parlin

    lead OTHER

Principal Investigators

  • Crystal Blake-Parlin · Pen Bay Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2022-09-06
Completion
2022-09-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04313296 on ClinicalTrials.gov